SCHEMBL11081096

SCHEMBL11081096

N#Cc1ccc2nc3n(c(=O)c2c1)CC/C3=C\c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.57
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ ALOX5 P09917 2/20 0.53
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ CCR3 P51677 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11081100 1.00 POLB (0.57) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11084370 0.94 POLB (0.66) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11084367 0.94 POLB (0.66) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11090294 0.92 POLB (0.64) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11090290 0.92 POLB (0.64) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11089791 0.88 NPC1 (0.53) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11089789 0.88 NPC1 (0.53) POLBNPC1RAB9ACYP1A2CYP3A4
SCHEMBL11083394 0.86 POLB (0.73) POLBNPC1RAB9AALOX5MEN1
SCHEMBL11083397 0.86 POLB (0.73) POLBNPC1RAB9AALOX5MEN1
SCHEMBL11086293 0.84 NPC1 (0.61) NPC1RAB9ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4428952-A Substituted pyrrolo[2,1-b]quinazolines and pyrido[2,1-b]quinazolines useful for the treatment of or the prevention of gastrointestinal ulcers FARMITALIA CARLO ERBA S.P.A. (IT) 1984-01-31 — — US disclosed
Send feedback